India markets open in 1 hour 13 minutes

Knight Therapeutics Inc. (GUD.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
6.00-0.04 (-0.66%)
At close: 4:00PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
90,344
47,461
12,500
8,634
5,940
Cost of revenue
45,837
20,543
2,305
1,585
1,550
Gross profit
44,507
26,918
10,195
7,049
4,390
Operating expenses
Research development
6,036
3,913
1,991
2,750
1,955
Selling general and administrative
46,239
32,249
12,055
11,576
9,834
Total operating expenses
61,301
39,575
15,978
15,955
12,226
Operating income or loss
-16,794
-12,657
-5,783
-8,906
-7,836
Interest expense
4,170
1,014
-
-
-
Total other income/expenses net
4,192
12,911
14,313
3,805
6,895
Income before tax
5,529
22,782
29,464
21,199
23,473
Income tax expense
2,162
4,749
5,385
3,955
4,913
Income from continuing operations
3,367
18,033
24,079
17,244
18,560
Net income
7,619
14,517
24,079
17,244
18,560
Net income available to common shareholders
7,619
14,517
24,079
17,244
18,560
Basic EPS
-
0.10
0.17
0.12
0.15
Diluted EPS
-
0.10
0.17
0.12
0.15
Basic average shares
-
1,39,759
1,42,828
1,42,764
1,20,723
Diluted average shares
-
1,40,139
1,43,275
1,43,417
1,21,264
EBITDA
-
28,066
-3,851
-7,277
-7,399